[go: up one dir, main page]

Duan, 1997 - Google Patents

Molecular characterization of adeno-associated virus for the gene therapy of submucosal gland in cystic fibrosis

Duan, 1997

Document ID
9943865275324379624
Author
Duan D
Publication year

External Links

Snippet

Cystic Fibrosis (CF) has emerged as a paradigm for the gene therapy of genetic disease. The full clinical potential of gene correction will only be achieved through a detailed understanding of both the target organ and the gene delivery vehicles. Dissection of the …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
    • C12N2750/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4712—Cystic fibrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system

Similar Documents

Publication Publication Date Title
US11680249B2 (en) Adeno-associated virus capsid variants and methods of use thereof
CN109641939B (en) Variant adeno-associated viruses and methods of use
US9585971B2 (en) Recombinant AAV capsid protein
JP5706602B2 (en) Gene therapy for Niemann-Pick disease type A
JP2023153788A (en) Promoters, expression cassettes, vectors, kits, and methods for treatment of achromatopsia and other diseases
JPH09509564A (en) Generation of high titer recombinant AAV vector
BR112013023185B1 (en) ISOLATED LINEAR NUCLEIC ACID MOLECULE, METHOD FOR PRODUCING AN ISOLATED LINEAR NUCLEIC ACID MOLECULE, IN VITRO METHOD TO MEDIATE EXOGENOUS DNA EXPRESSION IN A MAMMALIAN CELL, AND IN VITRO METHOD TO EFFECT THE EXPRESSION OF DESIRED GENE PRODUCT OR OLIGONUCLEOTIDE IN A CELL
JP2001506133A (en) AAV split-packaging genes and cell lines containing such genes for use in producing recombinant AAV vectors
CN103608455A (en) Promoters, expression cassettes, vectors, kits and methods for the treatment of color blindness and other diseases
CN112805382A (en) Variant RNAi against alpha-synuclein
AU2019323501B2 (en) Recombinant human type II mitochondrial dynein-like GTPase gene sequence and application thereof
Duan Molecular characterization of adeno-associated virus for the gene therapy of submucosal gland in cystic fibrosis
CN117940446A (en) Capsid variants and methods of use thereof
JP2023535025A (en) DNA binding domain transactivator and uses thereof
US10105450B2 (en) Promoter compositions
Woodbury et al. Gene delivery and gene therapy for Alzheimer’s disease
US20250302994A1 (en) Erythroparvovirus with a modified genome for gene therapy
US20130184332A1 (en) Vectors Containing the Max Gene
WO2024191877A2 (en) Human central nervous system (cns) targeting aav variants
Tang New biological tools for genetic manipulation of the mouse brain
CN117355603A (en) AAVRH74 vectors for gene therapy of muscular dystrophy
WO2024129992A1 (en) Enhancers driving expression in motor neurons
WO2025122565A1 (en) Targeting the g 4c 2 repeat-containing rna with a high-fidelity crispr-cas13 system improves abnormalities associated with als/ftd
JP2025512534A (en) Capsid variants and methods of using same
CN117979953A (en) Capsid variants and methods of use thereof